Events Partner Content Cell-Mediated Therapies for Infectious Disease Summit Cell-Mediated Therapies for Infectious Disease Summit
Views & Analysis How T-cell therapy saved my life Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy.
News Adaptimmune revives ovarian cancer trial T-cell trial will include controversial chemo agent fludarabine.
News Adaptimmune progresses T-cell therapy trial Biotech says "robust" clinical response in early stage trial.
Views & Analysis Promise for combination approach to cancer As immuno-oncology increasingly involves more than one agent for best efficacy, market positioning must take a pan-tumour approach.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
